TFRC and neoplasm: By exploiting breast cancer cells’ upregulated transferrinreceptor 1 (TfR1) expression and apoferritin (AFt) recognition, wesought to develop an AFt JAa-delivery vehicle to enhance tumor-targetingand reduce systemic toxicity.